AsthmaTrelegy Ellipta 184/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older. Trelegy Ellipta 184/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ICS/LABA.Important Limitations of UseTrelegy Ellipta 184/55/22 mcg is NOT indicated for the relief of acute asthma.Trelegy Ellipta 184/55/22 mcg is not indicated for patients with COPD.